Preethi Sundaram - Sep 15, 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Strategy Officer
Signature
/s/ Preethi Sundaram
Stock symbol
CPRX
Transactions as of
Sep 15, 2022
Transactions value $
-$163,926
Form type
4
Date filed
9/16/2022, 05:01 PM
Previous filing
Feb 16, 2022
Next filing
Nov 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $100K +18.2K $5.49 18.2K Sep 15, 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$264K -18.2K -100% $14.49 0 Sep 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 +18.2K +4.78% $0.00 399K Sep 15, 2022 Common Stock 18.2K $5.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons and not as a result of any disagreement with the Registrant. Dr. Sundaram remains an officer of the Company.